Shockwave Medical, Inc. (NASDAQ:SWAV) Shares Sold by Corient Private Wealth LLC

Corient Private Wealth LLC lessened its stake in Shockwave Medical, Inc. (NASDAQ:SWAVFree Report) by 7.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,464 shares of the company’s stock after selling 193 shares during the period. Corient Private Wealth LLC’s holdings in Shockwave Medical were worth $470,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Covestor Ltd boosted its position in Shockwave Medical by 484.9% in the 3rd quarter. Covestor Ltd now owns 427 shares of the company’s stock valued at $85,000 after buying an additional 354 shares during the period. International Assets Investment Management LLC boosted its position in Shockwave Medical by 18,122.1% in the 4th quarter. International Assets Investment Management LLC now owns 141,586 shares of the company’s stock valued at $26,981,000 after buying an additional 140,809 shares during the period. Massachusetts Financial Services Co. MA boosted its position in Shockwave Medical by 29.0% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 224,589 shares of the company’s stock valued at $42,798,000 after buying an additional 50,478 shares during the period. American Century Companies Inc. boosted its position in Shockwave Medical by 109.0% in the 3rd quarter. American Century Companies Inc. now owns 170,866 shares of the company’s stock valued at $34,019,000 after buying an additional 89,094 shares during the period. Finally, AMI Asset Management Corp purchased a new position in Shockwave Medical in the 4th quarter valued at approximately $4,092,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Insider Buying and Selling at Shockwave Medical

In other Shockwave Medical news, insider Isaac Zacharias sold 4,000 shares of Shockwave Medical stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $287.67, for a total value of $1,150,680.00. Following the transaction, the insider now directly owns 56,818 shares in the company, valued at $16,344,834.06. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Shockwave Medical news, Director Laura Francis sold 1,500 shares of Shockwave Medical stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $300.00, for a total value of $450,000.00. Following the transaction, the director now directly owns 3,551 shares in the company, valued at $1,065,300. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Isaac Zacharias sold 4,000 shares of the business’s stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $287.67, for a total transaction of $1,150,680.00. Following the transaction, the insider now owns 56,818 shares in the company, valued at $16,344,834.06. The disclosure for this sale can be found here. 3.40% of the stock is currently owned by company insiders.

Shockwave Medical Price Performance

Shares of SWAV opened at $334.75 on Friday. Shockwave Medical, Inc. has a 1-year low of $157.00 and a 1-year high of $334.90. The stock has a market cap of $12.57 billion, a PE ratio of 78.21, a price-to-earnings-growth ratio of 2.43 and a beta of 0.88. The company has a debt-to-equity ratio of 0.97, a current ratio of 13.81 and a quick ratio of 12.61. The firm has a fifty day moving average price of $329.69 and a 200 day moving average price of $260.86.

Shockwave Medical (NASDAQ:SWAVGet Free Report) last announced its quarterly earnings results on Monday, May 6th. The company reported $1.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.99 by $0.45. Shockwave Medical had a net margin of 20.75% and a return on equity of 24.79%. The firm had revenue of $218.80 million during the quarter, compared to analysts’ expectations of $207.69 million. During the same period in the previous year, the company earned $1.03 earnings per share. Shockwave Medical’s quarterly revenue was up 35.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that Shockwave Medical, Inc. will post 5.05 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have commented on SWAV. TheStreet raised shares of Shockwave Medical from a “c+” rating to a “b” rating in a research report on Thursday, February 15th. Piper Sandler lifted their price objective on shares of Shockwave Medical from $290.00 to $360.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 2nd. Canaccord Genuity Group reaffirmed a “hold” rating and set a $335.00 price objective (up from $263.00) on shares of Shockwave Medical in a research report on Friday, April 5th. Wolfe Research reaffirmed a “peer perform” rating on shares of Shockwave Medical in a research report on Friday, April 5th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Shockwave Medical in a research report on Friday, April 5th. Ten investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $309.11.

View Our Latest Report on Shockwave Medical

Shockwave Medical Profile

(Free Report)

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.

Featured Stories

Want to see what other hedge funds are holding SWAV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shockwave Medical, Inc. (NASDAQ:SWAVFree Report).

Institutional Ownership by Quarter for Shockwave Medical (NASDAQ:SWAV)

Receive News & Ratings for Shockwave Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shockwave Medical and related companies with MarketBeat.com's FREE daily email newsletter.